UK updates its Iran medical evidence: treatment availability, actual access and the legal test against removal

What was published and when the evidence ends

On 21 October 2026 the Home Office replaced its June 2024 Iran medical and healthcare note with an October 2026 country medical note. The new document says its country information covers material available on or before 21 September. Publication in October therefore does not mean every development up to October 21 has been incorporated.

The note is evidence about a country’s healthcare system, not an individual medical opinion or a decision that a particular person can safely be removed. Its value depends on how its sources relate to the claimant’s condition, treatment needs, location and practical ability to obtain care.

Availability on paper is only the starting question

The official country medical note surveys healthcare, treatment and costs. A reference to a service in one city does not establish access for a person living elsewhere. Likewise, the existence of a medicine does not answer whether a particular patient can afford it, obtain it continuously or safely use an alternative treatment.

A useful evidence plan links each disputed proposition to a record: the diagnosis and prognosis from the treating clinician, treatment requirements, relevant country information, likely costs and the person’s means of access. General assertions that healthcare is poor or expensive are less informative than evidence explaining the effect of a specific interruption on this patient.

The legal threshold is demanding and individual

The UK Supreme Court’s [AM (Zimbabwe) judgment, [2020] UKSC 17](https://supremecourt.uk/cases/uksc-2018-0048) addresses Article 3 medical-removal claims in light of Paposhvili. The assessment concerns a real risk of serious consequences arising from the absence of appropriate treatment or lack of access. It is not a general right to receive the best available care in the UK.

A medical condition should therefore be analysed under the correct human-rights framework rather than assumed to establish refugee status. A persecution claim, a medical Article 3 claim and an Article 8 family or private-life argument can involve overlapping facts but different legal questions. Combining them without identifying the relevant test can leave the decisive point unsupported.

How to use newer or conflicting evidence

Where developments after September 21 affect supply, travel or treatment access, identify them explicitly and explain why they change the assessment. A later report is not automatically more reliable; its author, methods, geographical coverage and connection to the claimant remain relevant. Preserve the source and date rather than relying on an unattributed social-media statement.

Consider a patient whose treatment is listed as available nationally but whose clinical records document that the alternative caused serious adverse effects. The issue is not resolved by quoting the national list alone. The decision maker needs evidence about medically suitable treatment and practical access, while the claimant must meet the applicable evidential threshold.

Planning a move to a third country

Relocation to Georgia raises a separate set of questions: lawful admission and stay, continuity of prescriptions, insurance, costs and specialist access. A UK country note does not create Georgian residence rights or establish Georgian healthcare availability. Consult the Georgian Aliens Law for the immigration framework and obtain current, case-specific information on treatment.

• Record the note’s publication date and evidence cutoff.
• Link country material to the individual medical facts.
• Address affordability, location and continuity where relevant.
• Check the decision’s remedy and deadline instead of assuming new evidence automatically suspends removal.

The updated note can improve the evidence base. The result still turns on the correct legal test and a credible account of the individual consequences.

Legal check date

Sources and law checked on 21 October 2026. Later developments are not reflected automatically. Application of the rules depends on the individual facts.